Levels of proprotein convertase subtilisin/kexin type 9 in patients with acute myocardial infarction by A. D. Gimadeeva, A. S. Galyavich, Z. M. Galeeva, L. V. Baleeva

Subjects: “…proprotein convertase subtilisin/kexin type 9…”
Get full text

ASSOCIATION OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 WITH HYPERTENSION AND SMOKING by K. S. Benimetskaya, M. P. Yachmeneva, S. V. Astrakov, L. V. Shcherbakova, D. V. Denisova, Yu. I. Ragino, M. I. Voevoda

Subjects: “…proprotein convertase subtilisin/kexin type 9…”
Get full text

Efficacy and safety of PCSK9 inhibitors in patients with chronic kidney disease by Haixia Tang, Xiaomin Li, Fengmei Wang, Hong Liu, Xiaoliang Zhang, Bicheng Liu, Bin Wang

Subjects: “…Proprotein convertase subtilisin/Kexin type 9 inhibitors…”
Get full text

PCSK9 in acute coronary syndrome: analysis of associations with clinical and laboratory characteristics by Yu. A. Drenina, K. Yu. Nikolaev

Subjects: Get full text

Silencing hepatic PCSK9 via novel chimeric AAV8 mitigates the progression of atherosclerosis by inhibiting inflammation in ApoE−/− mice by Xiaocui Chen, Minghui Sun, Xiang Ma, Yitong Ma, Bangdang Chen

Subjects: “…proprotein convertase subtilisin/kexin type 9…”
Get full text

Novel insights into the association between genetically proxied inhibition of proprotein convertase subtilisin/kexin type 9 and risk of sarcopenia by Hongyan Jiang, Lulu Li, Xue Zhang, Jia He, Chuanhuai Chen, Ruimin Sun, Ying Chen, Lijuan Xia, Lei Wen, Yunxiang Chen, Junxiu Liu, Lijiang Zhang, Wanqiang Lv

Subjects: Get full text

The importance of paying attention to the role of lipid-lowering drugs in controlling dengue virus infection by Omer Qutaiba B. Allela, Mohamad Ghazanfari Hashemi, Seyede Mozhgan Heidari, Radhwan Abdul Kareem, Hayder Naji Sameer, Mohaned Adil, Shaylan Kalavi

Subjects: Get full text

Natural phytochemicals as small-molecule proprotein convertase subtilisin/kexin type 9 inhibitors by Je-Wen Liou, Pei-Yi Chen, Wan-Yun Gao, Jui-Hung Yen

Subjects: Get full text

Pleiotropic Effects of PCSK9 Inhibitors on Cardio-Cerebrovascular Diseases by Zhenzhen Li, Lin Zhu, Yeqiong Xu, Yiting Zhang, Yukai Liu, Huiling Sun, Shuo Li, Meng Wang, Teng Jiang, Junshan Zhou, Qiwen Deng

Subjects: Get full text

Human PCSK9D374Y exacerbates methionine choline deficiency diet-induced nonalcoholic steatohepatitis in mice by Abidan·ABUDURUSULI, CHEN Xiaocui, CUI Yuanfeng, Tuoluonayi·MIJITI, DENG Lihui, CHEN Bangdang

Subjects: “…non-alcoholic steatohepatitis|proprotein convertase subtilisin/kexin type 9 (pcsk9)|methionine choline deficiency diet|inflammatory factor…”
Get full text

Association of Insomnia, Lipid Profile, and Lipid-Lowering Medications: A Narrative Review by Fang Jia, Shun-Yi Shi, Si-Fan Fei, Min Zhou, Jian-Jun Li

Subjects: Get full text

Proprotein convertase subtilisin/kexin type 9: a promising marker of cardiovascular risk in post-menopausal diabetic women in primary prevention by Michelangelo Rottura, Maria Antonietta Barbieri, Carmine Siniscalchi, Pierpaolo Di Micco, Selene Francesca Anna Drago, Marianna Gigliotti De Fazio, Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Giuseppe Armentaro, Angela Sciacqua, Vincenzo Arcoraci, Natasha Irrera, Egidio Imbalzano

Subjects: “…Proprotein convertase subtilisin/kexin type 9 (PCSK9)…”
Get full text

Lower On‐Treatment Low‐Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials by Antonio J. Vallejo‐Vaz, Henry N. Ginsberg, Michael H. Davidson, Robert H. Eckel, Christopher P. Cannon, L. Veronica Lee, Laurence Bessac, Robert Pordy, Alexia Letierce, Kausik K. Ray

Subjects: Get full text

Alirocumab and chest pain after acute coronary syndrome: An analysis of ODYSSEY OUTCOMES by Gregory P. Geba, Ruifeng Chen, Kasturi Talapatra, Taylor Brackin, Kusha A. Mohammadi, Robert Pordy, Garen Manvelian, David J. Maron, Gregory G. Schwartz, Michael Szarek, Ph. Gabriel Steg, Sergio Fazio

Subjects: Get full text

Anti-atherosclerotic effects of natural compounds targeting lipid metabolism and inflammation: Focus on PPARs, LXRs, and PCSK9 by Marcella Palumbo, Martina Ugolotti, Francesca Zimetti, Maria Pia Adorni

Subjects: Get full text

Increased serum PCSK9 levels are associated with renal function impairment in patients with type 2 diabetes mellitus by Zhicai Feng, Xiangyu Liao, Hao Zhang, Juan Peng, Zhijun Huang, Bin Yi

Subjects: “…Proprotein convertase subtilisin/kexin type 9…”
Get full text

The role of proprotein convertase subtilisin/kexin type 9 inhibitors in managing cardiovascular risk by Natalie Schellack, Gustav Schellack, E. Bronkhorst

Subjects: Get full text

MicroRNA-1912 regulates cholesterol homeostasis by targeting PCSK9 by Chan Joo Lee, Myeongjune Go, Sae-Bom Jeon, Sun-Ho Lee, Dongkook Min, So Hee Park, Seunghyun Lee, Sahng Wook Park

Subjects: Get full text

PCSK9 promotes T helper 1 and T helper 17 cell differentiation by activating the nuclear factor‐κB pathway in ankylosing spondylitis by Jianfei Cai, Yinghui Jiang, Fucai Chen, Shubin Wu, Hongjun Ren, Pingping Wang, Jiayong Wang, Wei Liu

Subjects: Get full text

Outpatient Practice of Lipid-Lowering Therapy Prescription (According to the ARGO-3 Study) by M. V. Ezhov, N. M. Akhmedzhanov, T. E. Kolmakova, A. V. Tyurina, A. I. Martynov

Subjects: Get full text